Lichen planus
☆ Kwiziphumo zika-2022 ze-Stiftung Warentest ezivela eJamani, ukwaneliseka kwabathengi ngeModelDerm bekungaphantsi kancinci kunokubonisana nge-telemedicine ehlawulweyo.
Izilonda ezibanzi kuzo zombini ii-shins zi-atypical. Kule meko, ezinye izifo ezingapheliyo (lichen simplex chronicus) zikholisa ukukrokreleka ngakumbi.
Atrophic lichen planus
References
Lichen planus (LP) yimeko yokuvuvukala ehlala ixesha elide echaphazela kakhulu abantu abadala kwiminyaka yabo ephakathi. Ingabonakala eluswini okanye kwiinwebu ze-mucous njengomlomo, ubufazi, ummizo, ibhokisi yelizwi, kunye nomgca wamehlo. I-LP iza ngeendlela ezahlukeneyo ngokuxhomekeka kwindlela i-rashes ekhangeleka ngayo kunye nalapho ivela khona. Uphononongo lucebisa ukuba ezinye iintlobo ze-LP, ezifana nezo zichaphazela ummizo okanye amehlo, zinokungafunyaniswa ngokwaneleyo. Ezinye iintlobo ze-LP, njengeentlobo ze-hypertrophic kunye ne-erosive emlonyeni, zinokuba ngumthwalo ngakumbi kwaye zihlala ixesha elide. Ezinye izinto ezinje ngamayeza okanye ukudibana nezinto ezithile kunokubangela irhashalala ekhangeleka ngendlela efanayo.
Lichen planus (LP) is a chronic inflammatory disorder that most often affects middle-aged adults. LP can involve the skin or mucous membranes including the oral, vulvovaginal, esophageal, laryngeal, and conjunctival mucosa. It has different variants based on the morphology of the lesions and the site of involvement. The literature suggests that certain presentations of the disease such as esophageal or ophthalmological involvement are underdiagnosed. The burden of the disease is higher in some variants including hypertrophic LP and erosive oral LP, which may have a more chronic pattern. LP can significantly affect the quality of life of patients as well. Drugs or contact allergens can cause lichenoid reactions as the main differential diagnosis of LP.
Lichen planus (LP) is a chronic inflammatory disorder that most often affects middle-aged adults. LP can involve the skin or mucous membranes including the oral, vulvovaginal, esophageal, laryngeal, and conjunctival mucosa. It has different variants based on the morphology of the lesions and the site of involvement. The literature suggests that certain presentations of the disease such as esophageal or ophthalmological involvement are underdiagnosed. The burden of the disease is higher in some variants including hypertrophic LP and erosive oral LP, which may have a more chronic pattern. LP can significantly affect the quality of life of patients as well. Drugs or contact allergens can cause lichenoid reactions as the main differential diagnosis of LP.
Lichen planus yimeko yolusu ephawulwa ngamaqhuma amfusa, anomphezulu osicaba kunye namabala anokubangela ukurhawuzelelwa kakhulu. Ezi zilonda zolusu zinokubangela uxinzelelo, ngakumbi xa zichaphazela umlomo okanye amalungu angasese kakhulu. Kwiimeko ezimandundu, oral lichen planus inokunyusa umngcipheko wokuba nohlobo lomhlaza wolusu. Inokuchaphazela i-scalp kunye nezikhonkwane. Nangona unobangela weemeko ezininzi ungaziwa, ezinye zisenokubangelwa ngamayeza athile okanye usulelo lwehepatitis C. Unyango lubandakanya iikhrimu ezinamandla kumatyala asekhaya kunye ne-oral steroids ezixhaphake kakhulu.
Lichen planus is a skin condition marked by purplish, flat-topped bumps and patches that can cause intense itching. These skin lesions can be distressing, especially when they affect the mouth or genitals severely. In severe cases, oral lichen planus may even increase the risk of developing a type of skin cancer. It can also affect the scalp and nails. While the cause of most cases is unknown, some may be triggered by certain medications or hepatitis C infection. Treatment typically involves strong creams for localized cases and oral steroids for more widespread ones.
Lichen planus is a skin condition marked by purplish, flat-topped bumps and patches that can cause intense itching. These skin lesions can be distressing, especially when they affect the mouth or genitals severely. In severe cases, oral lichen planus may even increase the risk of developing a type of skin cancer. It can also affect the scalp and nails. While the cause of most cases is unknown, some may be triggered by certain medications or hepatitis C infection. Treatment typically involves strong creams for localized cases and oral steroids for more widespread ones.
Lichen planus yimeko apho amajoni omzimba abangela ukudumba, okukhokelela kumanqaku ahlukileyo eluswini nakwiinwebu. Ichaphazela malunga ne-5% yabantu abadala, ngakumbi abasetyhini, kwaye ihlala iqala malunga nobudala obuphakathi. Ukubandakanyeka komlomo kubonakala kwi-77% yamatyala, amaninzi achaphazela isihlathi sangaphakathi. Ngelixa abanye abantu bengenakuziva naziphi na iimpawu, abanye banokuva iintlungu kwaye babe neengxaki ngokutya okuthile (umzekelo, i-acidic, i-spicy) okanye i-toothpaste.
Lichen planus is an immune-mediated inflammatory condition leading to characteristic lesions on skin and mucous membranes. It presents in up to 5% of the general adult population with a female predilection (2:1); the onset is most commonly in middle age. Up to 77% of patients with lichen planus have oral disease, with buccal mucosa the most common subsite. The oral lesions may be asymptomatic, although a subset of patients have pain and difficulty tolerating certain foods (e.g., acidic, spicy) and toothpaste.
Lichen planus is an immune-mediated inflammatory condition leading to characteristic lesions on skin and mucous membranes. It presents in up to 5% of the general adult population with a female predilection (2:1); the onset is most commonly in middle age. Up to 77% of patients with lichen planus have oral disease, with buccal mucosa the most common subsite. The oral lesions may be asymptomatic, although a subset of patients have pain and difficulty tolerating certain foods (e.g., acidic, spicy) and toothpaste.
Ukuqinisekisa ukuxilongwa kwe-cutaneous lichen planus, i-biopsy yesikhumba inokwenziwa. I-immunofluorescence ethe ngqo (DIF) ingaba luncedo kwizigulane ezinezilonda ze-bullous ukuhlula imeko kwi-autoimmune vesiculobullous disease.